This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2019
Title: The Innovations of Jean-Noel Levy
Introduction
Jean-Noel Levy is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrrolobenzodiazepines.
Latest Patents
One of his key patents is titled "Pyrrolobenzodiazepines and conjugates thereof." This patent describes a conjugate comprising a PBD dimer linked from the tether joining the two PBD units. The linker is defined by a specific formula, where R is selected from H and Calkyl. Additionally, L is a linker connected to a cell binding agent, and CBA represents the cell binding agent. The patent also specifies that n is an integer selected in the range of 0 to 48, and Q is defined as an amino-acid residue, a dipeptide residue, or a tripeptide residue. This patent showcases his innovative approach to drug design and development.
Career Highlights
Throughout his career, Jean-Noel Levy has worked with various companies, including Medimmune Limited. His work has contributed to advancements in therapeutic agents and drug formulations.
Collaborations
He has collaborated with notable individuals in the field, including Philip Wilson Howard and Stephen John Gregson. These collaborations have likely enriched his research and development efforts.
Conclusion
Jean-Noel Levy's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile